Welcome to our dedicated page for Olaplex Holdings news (Ticker: $OLPX), a resource for investors and traders seeking the latest updates and insights on Olaplex Holdings stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Olaplex Holdings's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Olaplex Holdings's position in the market.
Olaplex Holdings, Inc. (NASDAQ: OLPX) reported Q1 2024 results showing a 13.1% decrease in net sales to $98.9 million, with a 63.1% decrease in net income. The company reiterated fiscal year 2024 guidance with expectations for adjusted gross profit margin, adjusted SG&A, adjusted EBITDA margin, net interest expense, and adjusted effective tax rate. The company remains focused on driving sell-through and enhancing brand capabilities to meet their annual goals.